Introduction
============

In 1958, Cantrell and colleagues described the cases of five patients with a rare clustering of congenital defects, consisting of a midline, supraumbilical abdominal wall defect, a defect of the lower sternum, a deficiency of the anterior diaphragm, a defect in the diaphragmatic pericardium and intracardial defects \[[@B1]\]. We performed a chromosomal microarray analysis in a baby born with pentalogy of Cantrell that demonstrated a novel gain in copy number on an interval of 15q21.3. Among the genes found in the repeated segment was *ALDH1A2*, which encodes the enzyme retinaldehyde dehydrogenase type 2. Retinaldehyde dehydrogenase type 2 is critical for the conversion of vitamin A into all trans-retinoic acid, which is a morphogen that is known in vertebrate and avian models to be integral for normal cardiac development and diaphragm formation in the early stages of gestation. We believe this novel copy number variant in association with pentalogy of Cantrell may be significant and therefore report our experience with this patient.

Case presentation
=================

A 32-year-old G2P1 Caucasian expectant mother was referred for a fetal echocardiogram at an estimated gestational age of 20 weeks secondary to the presence of a fetal omphalocele. The echocardiogram demonstrated the fetus to have a large omphalocele, a lower sternal defect, and a midline cardiac apex with a small portion of the ventricles protruding through a pericardial and diaphragmatic defect onto the surface of the liver. The intracardiac anatomy was found to be consistent with tetralogy of Fallot. The care of the mother was transferred to a high-risk, maternal-fetal medicine physician with a plan for delivery at a tertiary care center and subsequent transfer to a nearby children's hospital for postnatal management.

The mother presented in active labor at 38 4/7 weeks' gestation. Rupture of membranes, with meconium staining, occurred one hour prior to delivery, and a male baby was delivered without complication via a vaginal birth after a Cesarean section. At delivery, the baby demonstrated no respiratory effort, and his heart rate was \<100 beats per minute. The baby was placed in a plastic bag and intubated on the first attempt. His heart rate quickly improved. A physical examination demonstrated a sternal defect covered by intact skin and a palpable cardiac impulse just beneath his skin at the level of the sternal cleft. There was a large, epigastric omphalocele containing visible liver, stomach and intestines. The remainder of the physical examination was normal, including a three-vessel umbilical cord. His birth weight was 3630g and Apgar scores were 2, 6 and 7 at 1, 5 and 10 minutes of life, respectively. Our patient was hemodynamically stable and was then transferred to our institution.

In our neonatal intensive care unit, we adopted a conservative management plan of the omphalocele: to forgo surgical repair and undertake daily dressing changes with antiseptic ointment while awaiting spontaneous epithelialization. Transthoracic echocardiography confirmed the presence of tetralogy of Fallot, with mild valvar pulmonary stenosis, and continuous, mildly hypoplastic branch pulmonary arteries. With spontaneous closure of the ductus arteriosus, our patient maintained a normal oxygen saturation level, and we planned for a complete repair on an elective basis at 3 to 6 months of age.

A computed tomography scan of his thorax confirmed the deficiency of his lower sternum, with the anterior aspect of his right ventricle just beneath the skin, as well as the deficiency of his anterior diaphragm (Figure [1](#F1){ref-type="fig"}). His liver, spleen and stomach were herniating through the anterior abdominal wall defect into the omphalocele. We found dependent atelectasis of his lungs. The remainder of the computed tomography scan and head and renal ultrasounds were normal. The baby was extubated on his 20th day of life, and continues to have daily dressing changes to the omphalocele at the time of writing.

![**Computed tomography scan.** A sagittal view from a contrast-enhanced computed tomography study demonstrating protrusion of the right ventricle through the sternal defect **(a)** and extra-abdominal position of the organs in the large omphalocele **(b)**.](1752-1947-7-287-1){#F1}

A 180K Oligo Chromosome Microarray Analysis, performed by Ambry Genetics (Aliso Viejo, CA, USA) was significant for a gain in copy number (x3) in chromosome 15q21.3 with a minimum interval from 57,529,846 to 58,949,448. Parental fluorescent *in situ* hybridization analysis using probe RP11-345H13 revealed the presence of a 15q21.3 duplication within the mother, indicating maternal inheritance from a phenotypically normal mother with no known diaphragmatic, sternal, pericardial, abdominal wall or intracardiac defects.

Discussion
==========

Microarray complete genome hybridization allows for high resolution, genome-wide screening for submicroscopic chromosomal imbalances. The technology has allowed screening of the entire genome for copy number variants and has proven useful in detecting imbalances in neonates with birth defects \[[@B2]\] and in patients with congenital heart disease \[[@B3],[@B4]\]. A microarray analysis does not specifically assess if a gain in copy number alters or disrupts the expression of the genes, but partial gene duplications would be anticipated to disrupt gene function \[[@B5]\]. Numerous studies have identified various copy number variants to play a role in structural birth defects, including congenital diaphragmatic hernia and various forms of congenital heart disease \[[@B6]\]. Screening babies with microarray analysis has become routine practice in many institutions in cases of selected congenital birth defects.

The specific region on chromosome 15q21.3 duplicated in our patient is known to contain nine genes: *ADAM10* (partially duplicated at the 3′ end), *ALDH1A2*, *AQP9*, *CGNL1*, *GCOM1*, *GRINL1A*, *LIPC*, *LOC283663* and *TCF12* (partially duplicated at the 5′ end). Only *ADAM10*, *ALDH1A2* and *LIPC* have been reported previously to have clinical significance. The clinical correlations reported for *ADAM10* and *LIPC* have no apparent relevance to our case.

An alteration in *ALDH1A2* may be clinically relevant in our patient. *ALDH1A2* (also known as *RALDH2*) codes for the enzyme retinaldehyde dehydrogenase type 2, which is crucial for the conversion of dietary vitamin A (retinol) to retinoic acid. Retinoic acid is known to be a powerful morphogen important during early development for axial patterning and in later development for organogenesis \[[@B7]\]. Retinoic acid cannot be synthesized *de novo* by animals, and must be obtained from preformed dietary vitamin A, which is then bound to retinol binding protein and transported into the cell by STRA-6, a membrane receptor. Within the cell, retinol is first oxidized to retinaldehyde, which is then further oxidized to retinoic acid. The oxidation to retinoic acid is catalyzed by the retinaldehyde dehydrogenase family of enzymes; of these three, retinaldehyde dehydrogenase type 2 is the major form involved in early embryonic and cardiac development \[[@B7]\].

The concentrations of retinoic acid are tightly regulated during development, and both deficiency and excess result in altered development in animal models \[[@B8]\]. The vertebrate heart is particularly sensitive to variations in retinoic acid signaling. Avian embryos subjected to vitamin A deficiency have been used to model vitamin A effects on very early heart development. The observed phenotypes included a grossly abnormal cardiovascular system. The critical time period for retinoic acid regulation corresponds to the first two to three weeks of human pregnancy \[[@B8]\]. This same embryologic period is associated with failed progression of the lateral mesoderm into the transverse septum of the diaphragm, which has been implicated to underlie pentalogy of Cantrell \[[@B1]\].

When screening 133 patients with congenital heart disease for variations within the *ALDH1A2* locus, Pavan *et al*. found two mutations in patients with tetralogy of Fallot that change polar to non-polar residues at exon 4 of the gene. The alteration hindered tetramerization of retinaldehyde dehydrogenase, demonstrating concrete potential to disrupt the activity of the enzyme and contribute to the etiology of tetralogy of Fallot \[[@B7]\], the intracardiac lesion in our patient.

The association between retinoic acid and congenital diaphragmatic hernia is also strong. A variety of studies provide a foundation for the hypothesis that retinoids play a key role in the formation of the pleuroperitoneal fold, the embryonic structure that gives rise to the diaphragm \[[@B9]\]. As early as the 1940s, it was noted that 25% to 40% of offspring from vitamin A-deficient rats developed diaphragmatic hernia. The rate of diaphragmatic herniation in these rats decreased when vitamin A was introduced into the diet during mid-gestation \[[@B10]\]. Four different teratogens noted to induce congenital diaphragmatic hernia in rats exert their effect through dose-dependent inhibition of retinaldehyde dehydrogenase type 2 \[[@B11]\]. One such toxin, nitrofen, has been associated with a 50% incidence of congenital diaphragmatic hernia, and periodic co-morbid occurrence of cardiac malformation is observed in affected specimens \[[@B12]\]. Plasma levels of retinol and retinol-binding protein in babies with congenital diaphragmatic hernia have been found to be decreased by half of that of healthy neonates \[[@B13]\], lending clinical credence to the role of retinoids in the setting of this defect.

The longstanding suggested mechanism for the development of pentalogy of Cantrell has been the developmental failure of a segment of the lateral mesoderm at gestational age 14 to 18 days. As a consequence, the paired mesodermal folds of the upper abdomen do not migrate ventromedially and the transverse septum of the diaphragm does not develop \[[@B1]\]. It is plausible that altered conversion of retinaldehyde to retinoic acid secondary to *ALDH1A2* dysfunction could contribute to the developmental failure seen in Cantrell's pentalogy. Analysis of complementary deoxyribonucleic acid (DNA) is required to determine if a maternal copy number gain is truly disruptive to retinoic acid concentrations in the developing fetus; however, it is plausible that such a gain is part of the mechanism underlying the pathology demonstrated in our patient with pentalogy of Cantrell.

Conclusion
==========

Given the robust evidence linking *ALDH1A2* to congenital diaphragmatic hernia, congenital heart disease in general, and tetralogy of Fallot in particular, it is a reasonable hypothesis that the gain in copy of the *ALDH1A2* gene in our patient and his mother played a role in the development of pentalogy of Cantrell. Further research targeting the *ALDH1A2* gene is warranted to ascertain the effect of copy number variants on the expression of retinaldehyde dehydrogenase type 2, and if subsequent alteration in maternal retinoic acid levels during development contribute to the etiology of pentalogy of Cantrell in children.
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